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Colorectal Cancer in Hadhramout Characteristics and Trends 
 
Rasheed Mohammed Bamekhlah*             Abdullah Saleh Bin Nabhan* 




Colorectal cancer is an important public health problem in the world, and there is no previous study in Hadhramout, 
Republic of Yemen about it so we aimed to describe characteristics and trends of colorectal cancer registered in 
Hadhramout National Oncology Center. A retrospective analysis of all registered cancers (2988) between 2002-2012, 
to describe colorectal cancer with regards to age, sex, subsites and histopathology and clinical presentation.  The 
results indicate that digestive system cancers are the most common cancers (15%); and colorectal cancer (30.9%) is 
the most common of these.  It was more common in males (57.2%). Colorectal cancer is the most common digestive 
cancers, more common in males, with higher tendency of early-onset. Most colorectal cancers were adenocarcinoma, 
and abdominal pain and rectal bleeding followed by altered bowel habit were the most common presentation. 
Keywords: Colorectal, cancer, Hadhramout, Yemen. 
 
Introduction: 
Colorectal cancer (CRC) is an important public 
health problem. it is the third most common 
cancer in men and the second most common 
cancer in women  after breast cancer worldwide 
[15,22]. There are nearly one million new cases 
diagnosed worldwide each year and 
approximately half a million death, making this 
cancer the fourth most common cause of death 
throughout the world, with a risk of occurrence 
of one out of every 20 individuals [6]. The 
developed countries account for >63% of the 
total global incidence. High-risk areas include 
North America, Europe, and Australia. Central 
and South America, Africa and Asia are areas 
with low risk factors [25]. There are many risk 
factors for CRC, some of which are not 
amenable to change. These include older person 
(>50 years), male sex, inflammatory bowel 
diseases, certain hereditary conditions and a 
family history of CRC or adenomatous polyps 
[2]. A great concern is recently paid for genetic 
factors [27], in addition to the role of 
environmental factors, these factors include low 
physical activity, [9], infection [8,13,14], tobacco 
[19], hyperinsulinemia associated with type II 
diabetes mellitus [11] and dietary factors [25]. 
However, 75% of all CRC occur in people with 
no known predisposing factors for the disease, 
this makes early detection and management with 
different screening modalities is an important 
mean for significant reduction in CRC incidence 
and mortality [2]. Currently, it is estimated that 
screening of the average risk people over the age of 
50 would reduce mortality for CRC by 50% [26]. 
In Hadramout, Republic of Yemen, data 
regarding this cancer are scarce. Therefore, this 
study was undertaken to highlight the 
characteristics and trend of this cancer through 
analyzing the data registered in Hadramout 
National Oncology Center (HNOC) during 11 
years period. 
 
Subjects and methods 
A descriptive, cross-sectional retrospective study 
for all registered cancers (2988 cases) in HNOC 
from January 2002 to December 2012 were 
performed, looking for CRC with regards to age, 
sex and, subsites and histopathological 
diagnosis,. As the clinical presentation data were 
not available before 2006, these were analyzed 
for the cases registered between 2006 - 2012 
only. The neoplasms had been coded and 
classified according to the international 
classification of diseases for oncology (ICD-O, 
3rd edition) [10]. 
 
Data processing and statistical analysis:  
All data collected were entered into a personal 
computer‚ using SPSS program version 20.0 
software for entering data and analysis purposes. 
Descriptive statistic such as frequencies and 
percentages were calculated and then study 
results were presented in tables and using Excel 
and Word programs. 
 
Results: 
Two thousand nine hundred and eighty-eight 
cases were registered during the 11 years study. 
Digestive system cancers (DCs) accounted for 
447 cases (15%) where the first ranking cancer 
among the registered cases. Among them, CRC 
(ICD-O 18-20) is the leading cancer (138 cases, 
30.9%) as shown in (Table 1). 
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Table (1): Subsites of digestive system Cancers (HNOC 2002-2012) 
 
Crude No. Site No % 
C-18-20 Colorectal 138 30.9 
C-22 Liver 90 20.1 
C-16 Stomach 88 19.7 
C-25 Pancreas 53 11.9 
C-15 Esophagus 40 8.9 
C-17 Small intestinal 15 3.3 
C-21 Anal 09 02 
C-24 Biliary tree 05 1.1 
C-17.0 Duodenum 03 0.7 
C-23 gallbladder 03 0.7 
C-26 Others GI cancers 03 0.7 
 Total 447 100 
 
Table 2 show that colon cancer was (75 cases, 
54.3%), rectum (59 cases, 42.8) and 
rectosigmoid (4 cases, 2.9%). By gender, 80 
cases were males (57.2%) compared to 58 
females (42.8%).  
In Table 3 the peak age of prevalence of all CRC 
was ≥ 70 years (29% of cases), followed by 
patients aged (60-69 years), cases ˂ 40 years are 
15.9%.  Rectal cancer in young patients was 
higher than colon cancer in the same age group 
(12 versus 8 cases), while Colon cancer in old 
patients was more than rectal cancers in the same 
age group (25 versus 15 cases).
 
Table (2): Sex distribution of Colorectal Cancer 
 
Cancer Male Female Total 
No. % No. % No. % 
Colon  (n=75) 43 57.3 32 42.7 75 54.3 
Rectum (n= 59) 35 59.3 24 40.7 59 42.8 
Rectosigmoid 
(n=04) 
02 50 02 50 04 02.9 
Total 80 57.2 58 42.8 138 100 
 











No. % No. % No. % No. % 
˂ 40 08 10.7 02 50 12 20.3 22 15.9 
40-49 10 13.3 00 00 06 10.2 16 11.6 
50-59 16 21.3 00 00 13 22 29 21 
60-69 16 21.3 02 50 13 22 31 22.5 
≥ 70 25 33.4 00 00 15 25.5 40 29 
Total 75 100 04 100 59 100 138 100 
 
The characteristics of CRC are demonstrated in 
(Table 4). Regarding the anatomic subsites of 
CRC, 39.9% were not specified as to subsites. 
The distribution of cancer across the remaining 
subsites revealed rectal and area preponderance 
(42.8%) with transverse colon as the least 
involved subsite (2.2%). For histopathological 
diagnosis, 46.4% of cases not specifically stated, 
and 50% were stated as adenocarcinoma.
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Table 5 shows that abdominal pain was the most 
common presentation in CRC (56.1% of cases), 
followed by rectal bleeding (34.8%), and altered 
bowel habit (28.8%), loss of weight (16.7%), 
anorexia and anemia (12.1% each). The least 
common presentation was abdominal mass 
(4.5%) followed by intestinal obstruction 
(10.6%).
 
Table (5): Clinical presentation of colorectal Cancer (Hadramout  
National Oncology Center 2006-2012). (n=66) 
 
Clinical presentation Frequency % 
Abdominal  pain 37 56.1 
Rectal bleeding 23 34.8 
Altered bowel  habit 19 28.8 
Loss of weight 11 16.7 
Anorexia 08 12.1 
Anemia 08 12.1 
Intestinal obstruction 07 10.6 
Abdominal mass 03 4.5 
 
Discussion: 
In spite of the presence of effective screening 
modalities, CRC is still an important cause of 
cancer-related morbidity and mortality whose 
risk is now increasing even in previously low 
risk areas [25]. The World Health Organization 
(WHO) foresees the overall global situation in 
respect to CRC will be worse [28]. The 
socioeconomic changes and urbanization, which 
take place in the Hadrami society, entails 
characterization of this cancer, which is usually 
linked with economic development. As our study 
limited to registered data in HNOC, many 
difficulties are faced in the interpretation of the 
results due to undetailed history and 
histopathological diagnosis and staging of the 
neoplasia. As a result of this, our study indicated 
that only 50% registered as adenocarcinoma, in 
contrast to what accepted globally that, up to 
98% of CRC are adenocarcinoma [25]. This 
would not reflect the real situation of this cancer 
in our community. However, our results will 
 Colorectal Cancers 
(n=138) 
No. % 
Subsites of the cancer 
Rectum 59 42.8 
Colon * 55 39.9 
Sigmoid  08 5.8 
Descending colon 05 3.6 
Rectosigmoid  04 2.8 
Transverse colon 03 2.2 
Caecum 03 2.2 
Hepatic flexure 01 0.7 
Total  138 100 
Histopathological diagnosis 
adenocarcinoma 69 50 
carcinoma * 64 46.4 
Squamous cell carcinoma  02 1.4 
Others 03 2.2 
Total  138 100 
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overview the characteristics of this cancer in the 
area covered by HNOC. The study demonstrated 
that CRC is the most common cancer in the 
digestive system. This is similar to what reported 
by Al-Radi et al., in Saudi Arabia [5] and Al-
Jabri et al., Jordan [4]. In developed countries, 
CRC is not only the most common digestive 
system cancer, but also a leading cancer either 
the third or the second cancer behind lung cancer 
in male and breast cancer among females [15]. 
Our results were in accordance with the literature 
regarding the occurrence of high number of cases 
among males [2,3,7,12,21,25]. Early age of 
incidence is a characteristic in developing 
countries. Under age of 40, there are more than 
one-third of cases in Egypt [1], 21.4% in Saudi 
Arabia [20] and 17% in Philippine,[17] 
compared to 3.6% in USA (18) and 7.6% in 
Canada [16], our work reported 15.9%. Studies 
from Egypt proposed that the high incidence of 
cancer in young people could not be explained 
on a hereditary basis nor can it be attributed to 
bilharziasis [1], or the widespread use of 
pesticides especially organochlorine [24]. In our 
community, bilharziasis, farming and pesticide 
use are relatively common, and further analytical 
studies could delineate its role together with 
other risk factors for CRC. Abdominal pain and 
rectal bleeding in our work were the most 
common clinical presentation of CRC, followed 
by altered bowel habits and these were similarly 
reported in many other studies [11,23,29]. 
Conclusion, the study demonstrated that CRC is 
the leading digestive system cancer. Despite 
limitations in the background history, detailed 
histopathological diagnosis and staging, the 
study indicated that developing countries 
characteristics as the presence of relatively high 
proportion of early-onset tumor is clear. 
Therefore, we recommend further in-depth 
studies, to address the possible community-
related risk factors of this cancer, education of 
the public about the nature of the disease, 
execution of screening programs for early 
detection and better outcome, detailed 
histopathological diagnosis and staging and 
improvement of cancer-reporting and registering 
activities. 
 
Limitation of the study: 
As the study was a retrospective there might be 
incomplete data in the HNOC archive. The 
center opened in 2000, and until 2005 no clinical 
data were documented and that is why we 




1- Issuing The Hadramout Cancer Registry is 
essential in our province. 
2- Prospective cancer studies are needed 
especially if concentrated on the society, the 
incidence, prevalence and the local risk factors. 
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   حضرموت: اخلصائص واالجتاهاتسرطان القولون يف
 
  عبدهللا صالح بن نبهان                         رشید دمحم  امخاله  
                الغزالي سعید حسین
  
  الملخص
  دراسة سا قة عن هذا المرض في حضرموت الجمهور ة أعلى مستو  العالم . ولكن التوجد سرطان القولون مش لة صح ة مهمة  د ع
اسة ع ارة عن تحلیل ورام  حضرموت. والدر ا الورم في سجل المر ز الوطني لألالخصائص واالتجاهات لهذهدفنا وصف استلهذا فقد . ال من ة
لون من حیث السن م لتوصیف سرطان القو 2012- 2002حالة) خالل الفتره بین  2988ورام المسجلة في هذا المر ز (أللكل حاالت ا
ورام الجهاز الهضمي أن عدد حاالت أ النتائجوضحت أفقد  كلین   ة.ألعراض األون والتشخ ص النسیجي و افي القول ةصا إلوالجنس وم ان ا
ورام الجهاز الهضمي. هذه أ%) من بین 30.9كثر (ألورام القولون اأخر  وتأتي ألورام األكثر شیوعا في حضرموت من األ%) هي ا15(
لم ال طن والنز ف أكثر شیوعا. و ألالورم الغد  هو ا  رة للسرطان.نه هناك میل للبدا ة الم إ%).  ما 57.2شیوعا عند الرجال ( كثرأورام ألا
  كثر ظهورا.ألعراض األا هيعبر المستق م یلیهما التغییر في عادة التبرز 
  : القولون، سرطان، حضرموت، ال من.الكلمات المفتاح ة
 
 
 
 
 
 
 
 
 
